Boston Scientific Invests $1.5 Billion in Atlanta-Based MiRus for Heart Valve Technology
Atlanta-based MiRus received a $1.5 billion investment from Boston Scientific for its heart valve technology.
Atlanta, GA, August 12, 2026 —
Atlanta, GA – MiRus, a company based in Atlanta, has secured a significant $1.5 billion investment from Boston Scientific. The investment is specifically for MiRus’s innovative heart valve technology.
The substantial funding from Boston Scientific, a global medical technology leader, underscores the potential and perceived value of MiRus’s advancements in the field of cardiac care. While the summary does not specify the exact nature of the heart valve technology, the investment suggests it represents a notable development in medical devices aimed at treating heart conditions.
Details regarding the timeline for the investment, specific milestones, or the intended use of the funds were not provided in the summary. Furthermore, information about MiRus’s operational history, the development stage of its heart valve technology, or any previous funding rounds was not included.
The agreement between the two companies marks a significant financial transaction in the medical technology sector. Boston Scientific’s investment indicates confidence in MiRus’s technological capabilities and its future prospects in the market. The full impact and deployment of this investment are expected to unfold as MiRus continues its development and commercialization efforts.
Story summarized from the original created by Google News on news.google.com, see more information here.
